D'Arena G, Musto P, Cascavilla N, Carotenuto M
Hematology Division, IRCSS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy.
Haematologica. 1998 Jul;83(7):587-92.
CD34+ hematopoietic progenitor cells (HPCs) constitute a heterogeneous population both in size and in immunological features. Lack of CD38, HLA-DR and lineage committed antigens as well as the co-expression of Thy-1 (CDw90) and c-kit receptor (CD117), are able to identify the so-called stem cells. A flow cytometric study was carried out to investigate the co-expression of Thy-1 and c-kit receptors, both members of Ig superfamily adhesion molecules, involved in cell to cell and cell to stroma interactions, on bone marrow (BM), mobilized peripheral blood (PB) and human umbilical cord blood (HUCB) CD34+ HPCs.
Lysed whole blood from 15 BM, 25 mobilized PB and 25 HUCB samples were used to perform a five-dimensional flow cytometric evaluation of both CDw90 and CD117 on CD34+ cells.
Few CD34+ cells co-expressed Thy-1 antigen in all three compartments (BM: 11.2 +/- 7.2%; PB: 6.2 +/- 3.6%; HUCB: 6 +/- 2.9%; BM vs PB < 0.04; BM vs HUCB < 0.008; PB vs HUCB ns). c-kit receptor was detected on the majority of CD34+ HPCs, particularly in HUCB (HUCB: 80.7 +/- 8.2%; BM: 72.3 +/- 13.1%; PB: 64.2 +/- 17%; HUCB vs BM < 0.03; HUCB vs PB < 0.0001; BM vs PB ns). CD34+Thy-1+ and CD34+c-kit+ HPCs generally displayed HLA-DR antigen, as expression of early cell commitment. However, the most immature CD34+Thy-1+HLA-DR- (HUCB: 1 +/- 0.6%; BM: 0.4 +/- 03%; PB: 0.7 +/- 0.5%; HUCB vs BM < 0.0001; BM vs PB < 0.04; HUCB vs PB ns) and CD34+c-kit+HLA-DR- HPCs (HUCB: 6.5 +/- 4.4%; BM: 6.3 +/- 4.8%; PB: 2.2 +/- 1.8%; HUCB vs BM ns; BM vs PB < 0.0001; HUCB vs PB < 0.0001) were mainly detected in HUCB. Finally, the greatest percentage of CD34+Thy-1+c-kit+ cells was found in BM (6.9 +/- 4.1%) followed by leukapheretic samples (4.4% +/- 2.7) and then by HUCB (3.7 +/- 1.2%; BM vs PB ns; BM vs HUCB < 0.001; HUCB vs PB ns).
Since the blood release or HPCs is probably due to a perturbation of the adhesive interactions between these cells and the marrow stroma, the different pattern of Thy-1 and c-kit receptor expression on CD34+ HPCs found in the three hemopoietic compartments evaluated can lead to new knowledge about the mobilization kinetics in which the Ig superfamily adhesion molecules are involved.
CD34+造血祖细胞(HPCs)在大小和免疫特征方面均构成一个异质性群体。缺乏CD38、HLA - DR和谱系特异性抗原以及Thy - 1(CDw90)和c - kit受体(CD117)的共表达,能够识别所谓的干细胞。进行了一项流式细胞术研究,以调查Thy - 1和c - kit受体在骨髓(BM)、动员外周血(PB)和人脐血(HUCB)的CD34+HPCs上的共表达情况,这两种受体均为免疫球蛋白超家族黏附分子成员,参与细胞间和细胞与基质间的相互作用。
使用来自15份骨髓、25份动员外周血和25份脐血样本的裂解全血,对CD34+细胞上的CDw90和CD117进行五维流式细胞术评估。
在所有三个组分中,很少有CD34+细胞共表达Thy - 1抗原(骨髓:11.2±7.2%;外周血:6.2±3.6%;脐血:6±2.9%;骨髓与外周血比较,P<0.04;骨髓与脐血比较,P<0.008;外周血与脐血比较,无显著差异)。在大多数CD34+HPCs上检测到c - kit受体,尤其在脐血中(脐血:80.7±8.2%;骨髓:72.3±13.1%;外周血:64.2±17%;脐血与骨髓比较,P<0.03;脐血与外周血比较,P<0.0001;骨髓与外周血比较,无显著差异)。CD34+Thy - 1+和CD34+c - kit+HPCs通常表达HLA - DR抗原,作为早期细胞分化的标志。然而,最不成熟的CD34+Thy - 1+HLA - DR-(脐血:1±0.6%;骨髓:0.4±0.3%;外周血:0.7±0.5%;脐血与骨髓比较,P<0.0001;骨髓与外周血比较,P<0.04;脐血与外周血比较,无显著差异)和CD34+c - kit+HLA - DR- HPCs(脐血:6.5±4.4%;骨髓:6.3±4.8%;外周血:2.2±1.8%;脐血与骨髓比较,无显著差异;骨髓与外周血比较,P<0.0001;脐血与外周血比较,P<0.0001)主要在脐血中检测到。最后,CD34+Thy - 1+c - kit+细胞的最大百分比在骨髓中发现(6.9±4.1%),其次是白细胞分离样本(4.4%±2.7),然后是脐血(3.7±1.2%;骨髓与外周血比较,无显著差异;骨髓与脐血比较,P<0.001;脐血与外周血比较,无显著差异)。
由于造血祖细胞的释放可能是由于这些细胞与骨髓基质之间黏附相互作用的扰动,在评估的三个造血组分中发现的CD34+HPCs上Thy - 1和c - kit受体的不同表达模式,可能会带来关于免疫球蛋白超家族黏附分子参与的动员动力学的新知识。